$3.90
0.082.09%
At close: -
$3.90
0.000.00%
After Hours: Apr 25, 4:00 PM EDT
Comments
Loading...
Agilon Health Analyst Ratings and Price Targets | NYSE:AGL | Benzinga
Agilon Health Inc has a consensus price target of $8.85 based on the ratings of 28 analysts. The high is $33 issued by Truist Securities on July 14, 2022. The low is $2 issued by TD Cowen on November 11, 2024. The 3 most-recent analyst ratings were released by Citigroup, TD Cowen, and Baird on April 25, 2025, April 15, 2025, and April 15, 2025, respectively. With an average price target of $5.33 between Citigroup, TD Cowen, and Baird, there's an implied 36.75% upside for Agilon Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
TD Cowen
Baird
Bernstein
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Agilon Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/25/2025 | Buy Now | 28.21% | Citigroup | Daniel Grosslight46% | $3.25 → $5 | Upgrade | Neutral → Buy | Get Alert |
| 04/15/2025 | Buy Now | 53.85% | TD Cowen | Ryan Langston23% | $3.5 → $6 | Maintains | Hold | Get Alert |
| 04/15/2025 | Buy Now | 28.21% | Baird | Michael Halloran64% | $6 → $5 | Maintains | Neutral | Get Alert |
| 04/08/2025 | Buy Now | 117.95% | Bernstein | Amir Farahan 5% | $3.3 → $8.5 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/21/2025 | Buy Now | — | Needham | Ryan MacDonald58% | — | Reiterates | Hold → Hold | Get Alert |
| 02/26/2025 | Buy Now | -10.26% | RBC Capital | Sean Dodge48% | $3 → $3.5 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Citizens Capital Markets | Constantine Davides38% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/26/2025 | Buy Now | -23.08% | Stifel | Craig Jones60% | $2 → $3 | Maintains | Hold | Get Alert |
| 02/26/2025 | Buy Now | — | Needham | Ryan MacDonald58% | — | Reiterates | Hold → Hold | Get Alert |
| 01/15/2025 | Buy Now | -19.23% | Bernstein | Amir Farahan 5% | $2.5 → $3.15 | Maintains | Market Perform | Get Alert |
| 01/10/2025 | Buy Now | -42.31% | Citigroup | Daniel Grosslight46% | $1.75 → $2.25 | Upgrade | Sell → Neutral | Get Alert |
| 01/10/2025 | Buy Now | — | Needham | Matthew Sheerin68% | — | Reiterates | Hold → Hold | Get Alert |
| 12/16/2024 | Buy Now | -23.08% | Macquarie | Tao Qiu43% | → $3 | Initiates | → Neutral | Get Alert |
| 12/11/2024 | Buy Now | -35.9% | Bernstein | Lance Wilkes66% | → $2.5 | Initiates | → Market Perform | Get Alert |
| 11/19/2024 | Buy Now | -23.08% | RBC Capital | Sean Dodge48% | $3 → $3 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | -55.13% | Citigroup | Daniel Grosslight46% | $2.5 → $1.75 | Maintains | Sell | Get Alert |
| 11/12/2024 | Buy Now | -48.72% | Stifel | Craig Jones60% | $7 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | -48.72% | TD Cowen | Gary Taylor60% | $6 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | -48.72% | Barclays | Andrew Mok54% | $5 → $2 | Maintains | Underweight | Get Alert |
| 11/11/2024 | Buy Now | — | JMP Securities | Constantine Davides38% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | — | William Blair | Ryan Daniels20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/29/2024 | Buy Now | -35.9% | Citigroup | Daniel Grosslight46% | $7 → $2.5 | Downgrade | Neutral → Sell | Get Alert |
| 10/08/2024 | Buy Now | 2.56% | Evercore ISI Group | Elizabeth Anderson44% | $7 → $4 | Maintains | In-Line | Get Alert |
| 10/02/2024 | Buy Now | -23.08% | B of A Securities | Kevin Fischbeck68% | → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/09/2024 | Buy Now | 2.56% | Deutsche Bank | George Hill62% | $5 → $4 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 130.77% | Benchmark | Bill Sutherland66% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 105.13% | RBC Capital | Sean Dodge48% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 07/09/2024 | Buy Now | 79.49% | Evercore ISI Group | Elizabeth Anderson44% | $5.5 → $7 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 53.85% | Baird | Michael Halloran64% | → $6 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | 66.67% | Truist Securities | Jailendra Singh37% | $6.4 → $6.5 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | 79.49% | Stifel | Craig Jones60% | $8 → $7 | Maintains | Hold | Get Alert |
| 04/22/2024 | Buy Now | 53.85% | Citigroup | Daniel Grosslight46% | → $6 | Initiates | → Neutral | Get Alert |
| 04/15/2024 | Buy Now | 64.1% | Truist Securities | Jailendra Singh37% | $7.5 → $6.4 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | 28.21% | Barclays | Andrew Mok54% | → $5 | Initiates | → Underweight | Get Alert |
| 02/29/2024 | Buy Now | 92.31% | Truist Securities | Jailendra Singh37% | $10 → $7.5 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 130.77% | Benchmark | Bill Sutherland66% | $13 → $9 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 53.85% | Evercore ISI Group | Elizabeth Anderson44% | $7 → $6 | Maintains | In-Line | Get Alert |
| 02/28/2024 | Buy Now | 105.13% | RBC Capital | Sean Dodge48% | $11 → $8 | Maintains | Outperform | Get Alert |
| 02/26/2024 | Buy Now | 105.13% | Wells Fargo | Stephen Baxter55% | $16 → $8 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 66.67% | TD Cowen | Gary Taylor60% | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | 130.77% | Stifel | Craig Jones60% | $10 → $9 | Maintains | Hold | Get Alert |
| 01/08/2024 | Buy Now | — | Wolfe Research | Justin Lake33% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/05/2024 | Buy Now | 156.41% | Truist Securities | Jailendra Singh37% | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | Buy Now | 130.77% | JP Morgan | Lisa Gill59% | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 12/13/2023 | Buy Now | 335.9% | JP Morgan | Lisa Gill59% | $36 → $17 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse60% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | Buy Now | 361.54% | JMP Securities | Constantine Davides38% | → $18 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | Buy Now | 207.69% | Deutsche Bank | George Hill62% | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2023 | Buy Now | 464.1% | Benchmark | Bill Sutherland66% | $28 → $22 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 310.26% | Wells Fargo | Stephen Baxter55% | $23 → $16 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 489.74% | Truist Securities | Jailendra Singh37% | $27 → $23 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 464.1% | Goldman Sachs | Jamie Perse60% | $25 → $22 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 489.74% | RBC Capital | Sean Dodge48% | $28 → $23 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | 617.95% | Benchmark | Bill Sutherland66% | → $28 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 541.03% | Goldman Sachs | Jamie Perse60% | $29 → $25 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 541.03% | TD Cowen | Gary Taylor60% | $29 → $25 | Maintains | Outperform | Get Alert |
| 06/20/2023 | Buy Now | 592.31% | Truist Securities | Jailendra Singh37% | $35 → $27 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 476.92% | Evercore ISI Group | Elizabeth Anderson44% | → $22.5 | Initiates | → In-Line | Get Alert |
| 05/31/2023 | Buy Now | 643.59% | Goldman Sachs | Jamie Perse60% | $32 → $29 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 592.31% | Deutsche Bank | George Hill62% | $28 → $27 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 746.15% | RBC Capital | Sean Dodge48% | → $33 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 720.51% | Stifel | Craig Jones60% | $29 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 797.44% | Truist Securities | Jailendra Singh37% | $29 → $35 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 669.23% | Guggenheim | Sandy Draper74% | $21 → $30 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 617.95% | Deutsche Bank | George Hill62% | $26 → $28 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | 489.74% | Stifel | Craig Jones60% | → $23 | Initiates | → Buy | Get Alert |
| 11/15/2022 | Buy Now | 771.79% | Goldman Sachs | Jamie Perse60% | $38 → $34 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | 464.1% | Wells Fargo | Stephen Baxter55% | $28 → $22 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 669.23% | SVB Leerink | Whit Mayo66% | $33 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | 746.15% | RBC Capital | Sean Dodge48% | → $33 | Initiates | → Outperform | Get Alert |
| 09/12/2022 | Buy Now | 874.36% | Goldman Sachs | Jamie Perse60% | → $38 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | 643.59% | Truist Securities | Jailendra Singh37% | $33 → $29 | Assumes | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 617.95% | Wells Fargo | Stephen Baxter55% | $23 → $28 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 669.23% | Deutsche Bank | George Hill62% | $29 → $30 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | 746.15% | Truist Securities | David Macdonald64% | $30 → $33 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | — | BTIG | David Larsen44% | — | Initiates | → Neutral | Get Alert |
| 06/08/2022 | Buy Now | 566.67% | Deutsche Bank | George Hill62% | $26 → $26 | Maintains | Buy | Get Alert |
| 05/10/2022 | Buy Now | 566.67% | Deutsche Bank | George Hill62% | → $26 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Agilon Health (AGL) stock?
The latest price target for Agilon Health (NYSE:AGL) was reported by Citigroup on April 25, 2025. The analyst firm set a price target for $5.00 expecting AGL to rise to within 12 months (a possible 28.21% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Agilon Health (AGL)?
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Citigroup, and Agilon Health upgraded their buy rating.
When was the last upgrade for Agilon Health (AGL)?
The last upgrade for Agilon Health Inc happened on April 25, 2025 when Citigroup raised their price target to $5. Citigroup previously had a neutral for Agilon Health Inc.
When was the last downgrade for Agilon Health (AGL)?
The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.
When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on April 25, 2025 so you should expect the next rating to be made available sometime around April 25, 2026.
Is the Analyst Rating Agilon Health (AGL) correct?
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a upgraded with a price target of $3.25 to $5.00. The current price Agilon Health (AGL) is trading at is $3.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
